The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Investment firmnbank-capital.deSince 2026-09-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Allogenetics Allogenetics offers innovative gene therapy solutions to modify donor organs, making them invisible to the recipient's immune system and eliminating the need for lifelong immunosuppression. | Bridge Developing, 7 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $4.4M | 2026-09-09 | [ LEAD ] |